chr1-215879002-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BS1_SupportingBP4

This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the p.Ala2774Thr variant in the USH2A gene is 0.07463% (931/1179918) of European (non-Finnish) chromosomes in gnomAD v4 (BS1_Supporting). The computational prediction analysis tool REVEL predicted a score of 0.052, which meets the threshold to apply BP4. In summary, this variant meets the criteria to be classified as likely benign based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: BS1_Supporting, BP4. (ClinGen Hearing Loss VCEP specifications version 2; 03/12/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA143621/MONDO:0019501/005

Frequency

Genomes: 𝑓 0.00057 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00072 ( 1 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

19

Clinical Significance

Likely benign reviewed by expert panel U:2B:8

Conservation

PhyloP100: 1.38

Publications

13 publications found
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 39
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.8320G>A p.Ala2774Thr missense_variant Exon 42 of 72 ENST00000307340.8 NP_996816.3 O75445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.8320G>A p.Ala2774Thr missense_variant Exon 42 of 72 1 NM_206933.4 ENSP00000305941.3 O75445-1
USH2AENST00000674083.1 linkc.8320G>A p.Ala2774Thr missense_variant Exon 42 of 73 ENSP00000501296.1 O75445-3

Frequencies

GnomAD3 genomes
AF:
0.000565
AC:
86
AN:
152082
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00170
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000853
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000544
AC:
136
AN:
250090
AF XY:
0.000577
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00134
Gnomad NFE exome
AF:
0.000694
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.000718
AC:
1050
AN:
1461772
Hom.:
1
Cov.:
32
AF XY:
0.000683
AC XY:
497
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33478
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000499
AC:
43
AN:
86258
European-Finnish (FIN)
AF:
0.00122
AC:
65
AN:
53416
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.000785
AC:
873
AN:
1111904
Other (OTH)
AF:
0.00101
AC:
61
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
61
122
183
244
305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000565
AC:
86
AN:
152200
Hom.:
1
Cov.:
32
AF XY:
0.000578
AC XY:
43
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41532
American (AMR)
AF:
0.0000655
AC:
1
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
0.00170
AC:
18
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000853
AC:
58
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000628
Hom.:
2
Bravo
AF:
0.000382
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000544
AC:
66
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.000474

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:2Benign:8
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Usher syndrome type 2A Uncertain:1Benign:2
Nov 19, 2021
Myriad Genetics, Inc.
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NM_206933.2(USH2A):c.8320G>A(A2774T) is a missense variant classified as a variant of uncertain significance. A2774T has been observed in cases of USH2A-related disorders (PMID: 25133751, 28041643). Functional studies on this variant are not available. A2774T has been observed in population frequency databases (gnomAD: EUR 0.14%). In summary, there is insufficient evidence to classify NM_206933.2(USH2A):c.8320G>A(A2774T) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. -

May 03, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 18, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32707200, 28041643) -

Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

USH2A: BP4, BS2 -

Retinal dystrophy Uncertain:1
Jan 01, 2015
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

not specified Benign:1
Feb 17, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome Benign:1
Mar 12, 2025
ClinGen Hearing Loss Variant Curation Expert Panel
Significance:Likely benign
Review Status:reviewed by expert panel
Collection Method:curation

The filtering allele frequency of the p.Ala2774Thr variant in the USH2A gene is 0.07463% (931/1179918) of European (non-Finnish) chromosomes in gnomAD v4 (BS1_Supporting). The computational prediction analysis tool REVEL predicted a score of 0.052, which meets the threshold to apply BP4. In summary, this variant meets the criteria to be classified as likely benign based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: BS1_Supporting, BP4. (ClinGen Hearing Loss VCEP specifications version 2; 03/12/2025). -

Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Benign:1
May 11, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
0.056
DANN
Benign
0.66
DEOGEN2
Benign
0.015
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.25
T
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.23
N
PhyloP100
1.4
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.41
N
REVEL
Benign
0.052
Sift
Benign
0.39
T
Sift4G
Benign
0.41
T
Polyphen
0.039
B
Vest4
0.084
MVP
0.71
MPC
0.030
ClinPred
0.0088
T
GERP RS
0.59
Varity_R
0.027
gMVP
0.24
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111033533; hg19: chr1-216052344; COSMIC: COSV56338896; API